Study of osteopontin as the "CA125" adjunct for detection of ovarian carcinoma in patients with pelvic mass

ABSTRACT

Introduction: Ovarian cancer is the most lethal gynecologic cancer, whose high mortality rate is partly due to late diagnosis. Tumor-specific markers that can be detected in early stages of the disease could probably improve treatment results. In this study, we evaluated the diagnostic value of serum levels of osteopontin in patients with epithelial ovarian tumors